GlaxoSmithKline's June announcement that it was cutting 350 jobs [1] worldwide is coming to fruition. The company just laid off 22 scientists at its Medicinal Chemistry and Oncology Department in Research Triangle Park, North Carolina.
Already this summer, the company laid off nearly 200 workers, with half in its research department in June and about 90 more from a manufacturing plant in Zebulon. Company spokespeople say its just part of GSK's overall R&D "restructuring" plan to increase research and development and make manufacturing more efficient.
- read more [2] at the News & Observer
- see the Herald Sun story [3]
Related Articles:
Big Pharma's biotech shift means layoffs for chemists [4]
Ailing GlaxSmithKline to axe 350 R&D workers [1]
GSK plant closure begins 5,000 job cuts [5]
Links:
[1] http://www.fiercepharma.com/story/ailing-glaxsmithkline-axe-350-r-d-workers/2008-06-12
[2] http://www.newsobserver.com/1565/story/1165556.html
[3] http://heraldsun.southernheadlines.com/business/21-976980.cfm
[4] http://www.fiercebiotech.com/story/big-pharma-s-biotech-shift-means-layoffs-chemists/2007-12-11
[5] http://www.fiercepharma.com/story/gsk-plant-closure-begins-5-000-job-cuts/2007-10-25